Navigation Links
Risks and benefits of antipsychotics in children and adolescents
Date:9/1/2008

ty, and tolerability of antipsychotics in children and adolescents (Arango et al. 2004; Kumra et al. 2007). In our context, the most commonly prescribed antipsychotics in this population are risperidone, quetiapine, and olanzapine (Castro-Fornieles et al., in press). Recently, the new EC regulation on medicinal products for paediatric use aimed to improve the information available to prescribers and families, forcing drug companies to conduct clinical trials with this population in order to reduce off-label use (=non-approved use).

Clinical trials of antipsychotic drugs traditionally focus on acute clinical efficacy and tolerability. However, pharmacological interventions in children and adolescents with mental disorders must meet broader requirements of clinical effectiveness to provide the best possible outcome in terms of individual well-being, social and educational and/or vocational functioning, and disease burden. They must also take into account long-term safety issues and the possible interaction of the drugs with a developing brain. Developmental changes occurring during childhood and adolescence may influence both treatment response and drug tolerability in ways not seen in adults. It is also possible that treatment may adversely affect cognitive development, exacerbating functional problems and limiting clinical effectiveness. Alternatively, early intervention with an effective and well-tolerated antipsychotic may provide benefits that may modify the actual course of the disease in some paediatric mental disorders (Arango et al., 2004).

Efficacy

Antipsychotics have shown efficacy in the treatment of psychotic disorders in children and adolescents (schizophrenia, bipolar disorders), as well as conduct disorders, Tourette syndrome, and tics (Jensen et al., 2007; Kumra et al., 2008; Findling et al., 2008). In the first study comparing 3 different second-generation antipsychotics (SGAs) in 110 patients with early onset psychosis (mean
'/>"/>

Contact: Sonja Mak
s.mak@update.europe.at
43-140-557-340
European College of Neuropsychopharmacology
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. NAS report offers new tools to assess health risks from chemicals
2. Less Arctic ice means higher risks, experts warn
3. Energy drinks may pose risks for people with high blood pressure, heart disease
4. Fresh-cut produce washing practices can minimize food-borne illness risks
5. Turtle studies suggest health risks from environmental contaminants
6. Too much or too little weight gain poses risks to pregnant mothers, babies
7. Baker Institute study, conference weigh risks for global energy markets
8. Tufts University biologists link Huntingtons disease to health benefits in young
9. The benefits of 80 million years without sex
10. New data shows benefits of MitraClip for patients with mitral regurgitation
11. RAND paper finds diesel, hybrid vehicles can provide more societal benefits than gas-powered autos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2015)... /CNW Telbec/ - handyem Inc. and FlowMetric Diagnostics ... of handyem,s HPC-150 portable flow cytometer within FlowMetric ... unprecedented model of mobile laboratory platform is presented ... Pennsylvania Convention Center, ... to 18 th 2015.  By virtue of ...
(Date:6/16/2015)... Sweden , June 16, 2015 ... from previously communicated that it will amount to at least ... MSEK. Due to the rapid increase in market growth and ... the previously communicated guidance that revenue for 2015 will exceed ... will amount to approximately 2,200 MSEK. Due to ...
(Date:6/15/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a ... announces that its leading payment security technology, the Wocket® smart ... NYC June 18th. Digital Experience! @ NYC is ... to over 300 of the top media covering the sector. ... New York City from 6:00 to ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
... 2012 In a study published in the March ... Academy of Child and Adolescent Psychiatry , Katherine Rice ... of Atlanta, and Emory University School of Medicine, used ... social disability in children with autism spectrum disorders (ASD) ...
... team of researchers show that most neandertals in Europe died ... a Europe populated by a stable neandertal population for hundreds ... therefore be revised. This new perspective on the ... in Molecular Biology and Evolution . The results indicate ...
... PHOENIX, Ariz. Feb. 27, 2012 The 9th ... pancreatic cancer research at the Translational Genomics Research Institute ... will go toward new international clinical trials run by ... first time that major retailers, producers and suppliers in ...
Cached Biology News:Eye-tracking reveals variability in successful social strategies for children with autism 2European Neandertals were on the verge of extinction even before the arrival of modern humans 2Celebrity Golf Classic raises $553,443 for Seena Magowitz Foundation 2
(Date:7/6/2015)... 2015 Navitas, a leading Regulatory Service provider, today announced that ... in Bogota, Colombia . Navitas, expansion into ... by Colombia , the third largest economy in ... Logo - http://photos.prnewswire.com/prnh/20150703/228239LOGO ... clients to communicate with Navitas regulatory professionals in close to or the ...
(Date:7/3/2015)... Texas (PRWEB) , ... July ... ... biotechnology company providing industry-leading products for use in applications such as animal ... in wastewater treatment plants and restaurant kitchen settings, announced today that it ...
(Date:7/3/2015)... , ... July 03, 2015 , ... The global failure ... 7.52% from 2015 to 2020. The bioscience market is expected to grow at the ... use of failure analysis equipment in the research labs and academic institutions for root ...
(Date:7/3/2015)...  Pomerantz LLP announces that a class action lawsuit ... the "Company")(NYSE: PBYI ) and certain of its ... Court, Central District of California , ... class consisting of all persons or entities who purchased ... 2015 inclusive (the "Class Period").  This class action seeks ...
Breaking Biology Technology:Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 2Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 3DryLet to Highlight Benefits of Patented ManureMagicâ„¢ at North American Manure Expo in Chambersburg, PA July 14-15, 2015 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 4Failure Analysis Market to Grow at 7.52% CAGR to 2020 5SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 2SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 4
... Aug. 20 GSI Group Inc.,(Nasdaq: GSIG ) ... the tender offer by its indirect wholly-owned subsidiary Eagle,Acquisition ... of,Excel Technology, Inc. (Nasdaq: XLTC ). The initial ... City time, on Tuesday, August 19,2008., The depositary ...
... Strategic Fit with Lilly,s Animal Health Division, GREENFIELD, ... and Company (NYSE: LLY ), today announced that ... to the dairy cow supplement,Posilac(R) (sometribove), as well as ... )., "Global dairy demand is increasing, outstripping supply, ...
... has selected OpenClinica as its electronic data capture (EDC) and ... , ... Ruetlingen, Germany (PRWEB) August ... has selected OpenClinica as its http://www.openclinica.org/section.php?sid=1 [electronic data ...
Cached Biology Technology:GSI Group Accepts Shares in Tender Offer for Excel Technology and Commences Subsequent Offering Period 2GSI Group Accepts Shares in Tender Offer for Excel Technology and Commences Subsequent Offering Period 3Elanco Announces Acquisition of Posilac(R) Dairy Business 2Elanco Announces Acquisition of Posilac(R) Dairy Business 3OpenClinica EDC Solution Deployed for Retina Implant Studies 2OpenClinica EDC Solution Deployed for Retina Implant Studies 3
Monoclonal Anti-Gα o purified immunoglobulin buffered aqueous solution Solution in phosphate buffered saline pH 7.4, containing 0.08% sodium azide. partially purified bovine brain Gα O ...
Anti human PPAR gamma2 mouse monoclonal antibody...
Mouse monoclonal [RIZ1723] to PRDM2/RIZ...
... Reacts with an early ... infection 3 hours post-infection exhibiting ... reaches peak intensity between 6-24 ... extremely intense coarsely granular staining. ...
Biology Products: